Also trades as: 0HFR.L (LSE) · $vol 0M
AVXL NASDAQ
Anavex Life Sciences Corp.
1W: -12.0%
1M: -24.9%
3M: -34.2%
YTD: -26.4%
1Y: -64.0%
3Y: -69.9%
5Y: -75.5%
$2.69
-0.01 (-0.55%)
Weekly Expected Move ±7.7%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-40M
Net Income
+14.1% YoY
$-34M
Free Cash Flow
+4.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-37.1%
ROA-33.4%
ROIC457.1%
Valuation
P/E-6.0
P/B1.9
EV/EBITDA-8.1
Leverage
Debt/Equity0.00
Current Ratio11.60
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z15.96
Beneish M0.00